Almac Group
Craigavon, United Kingdom
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
○ EMA GMP
○ MHRA GMP
Quick Facts: Almac Group
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Craigavon, United Kingdom
- Modalities
- Peptide API, Small Molecule API, HPAPI, Drug Product (Oral, Injectable), Analytical Services
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Almac Group
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesPeptide API, Small Molecule API, HPAPI, Drug Product (Oral, Injectable), Analytical Services
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (5 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press10 articles
Broad modality coverage (5 modalities)
Recent News 10 articles
As many CDMOs battle post-pandemic sales downturn, Almac's revenue jumps amid global expansion push - Fierce Pharma
Newsmakers Q&A: Almac Group - Contract Pharma
Growing Almac boosts capacity for manufacturing peptides and packaging commercial products - Fierce Pharma
Almac makes $48M commitment to eClinical offering with new trial coordinator platform - Fierce Biotech
CDMO Almac continues expansion spree with new £65M UK oral treatment plant - Fierce Pharma
Almac Group Unveils Latest GMP Facility - Pharmaceutical Commerce
Almac Group Grows Northern Ireland HQ, Welcomes New Facilities - Pharmaceutical Commerce
CDMO Almac continues its expansion momentum with lab deal - Fierce Pharma
Almac Pharma Services Expands Its Unique Ultra-Low Temperature Solutions for Advanced Therapy Medicinal Products - newswire.com
Almac Group extends personalised cancer vaccine production facilities - Express Pharma
Frequently Asked Questions About Almac Group
What is Almac Group's CDMO Signal Score?
Almac Group has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Almac Group for a manufacturing program?
Use the free AI matchmaker to compare Almac Group against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Fermion (Orion Group)
Espoo, Finland
Small Molecule API, HPAPI, Semi-solid drug product (creams, gels, ointments), Hormonal products
Veranova
Devens, MA
Small Molecule API, HPAPI, ADC payload/linker, Oligonucleotide, Peptide
Sai Life Sciences
Hyderabad, India
Small Molecule API, Complex Small Molecules, HPAPI, ADC, Peptides, Oligonucleotides, Lipids / LNP, Intermediates, Drug Discovery (CRO)
Cambrex Corporation
East Rutherford, NJ
Small Molecule API, HPAPI, Controlled Substances, Oral Solid Dose, Solid State Research, Particle Engineering, Drug Product (OSD), Controlled Release
Ardena
Ghent, Belgium
Small Molecule API, Solid-State Research, HPAPI, PROTACs / Molecular Glues, Nanomedicine / LNP, Drug Product (Oral, Injectable, Semi-solid), CMC Regulatory, Bioanalysis